Cargando…
Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Although a cadre of therapeutic strategies have been made available for CVDs in the clinical setting, predominantly through medication and surgery, these do not fully address the clinical needs of patients with C...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049183/ https://www.ncbi.nlm.nih.gov/pubmed/36982284 http://dx.doi.org/10.3390/ijms24065205 |